Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Chubb
AstraZeneca
UBS
Baxter
Colorcon
US Department of Justice
Cipla
Fuji
Citi

Generated: October 21, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: High affinity nucleic acid ligands containing modified nucleotides
Abstract:Nucleic acid ligands containing modified nucleotides are described as are methods for producing such oligonucleotides. Such ligands enrich the chemical diversity of the candidate mixture for the SELEX process. Specific examples are provided of nucleic acids containing nucleotides modified at the 2'- and 5-position. Specific 2-OH and 2'-NH.sub.2 modified RNA ligands to thrombin are described.
Inventor(s): Pieken; Wolfgang (Longmont, CO), Tasset; Diane (Boulder, CO), Janjic; Nebojsa (Lafayette, CO), Gold; Larry (Boulder, CO), Kirschenheuter; Gary P (Arvada, CO)
Assignee: NeXstar Pharmaceuticals, Inc. (Boulder, CO)
Filing Date:Sep 27, 1999
Application Number:09/407,234
Claims:1. A method of preparing 5-iodo,2'-amino deoxyuridine from uridine comprising:

a) dehydrating uridine to 2,2'-anhydrouridine;

b) converting 2,2'-anhydrouridine to an unprotected 2'-azido,2'-deoxyuridine;

c) iodinating the unprotected 2'-azido,2'-deoxyuridine to 5-iodo, 2'-azido,2'-deoxyuridine; and

d) reducing the unprotected 5-iodo,2'-azido,2'-deoxyuridine to 5-iodo,2'-amino,2'-deoxyuridine.

2. A method of preparing 5-iodo,2'-amino,2'-deoxy uridine 5'-triphosphate from 2'-amino,2'-deoxyuridine, comprising:

a) trifluoroacetylating 2'-amino,2'-deoxyuridine to form 2'-trifluoroacetylamino,2'-deoxyuridine;

b) phosphorylating 2'-trifluoroacetylamino,2'-deoxyuridine to 2'-amino,2'-deoxyuridine 5'-triphosphate; and

c) iodinating 2'-trifluoroacetylamino,2'-deoxyuridine by mercuration to form 5'-iodo,2'-amino,2'-deoxyuridine 5'-triphosphate.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
QuintilesIMS
Cantor Fitzgerald
Argus Health
Chinese Patent Office
Fish and Richardson
McKinsey
AstraZeneca
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot